PharmaShots | Incisive News in 3 Shots

Subscribe Now

OrsoBio

OrsoBio Reports the First Patient Dosing of TLC-3595 in P-IIa Clinical Trial for the Treatment of Type 2 Diabetes

OrsoBio Reports the First Patient Dosing of TLC-3595 in P-IIa Clinical Trial for the Treatment of Type 2 Diabetes

March 21, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us